Drug Archive
FDA-approved oncology drugs with resistance mutation data
| Drug Name | Class | Targets | Resistance Mutations | |
|---|---|---|---|---|
|
Abarelix
|
— | 1 | — | View → |
|
Abiraterone
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol, 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
|
— | 1 | — | View → |
|
Afatinib
Afatinibum
|
EGFR Inhibitor | 3 | 10 | View → |
|
Aflibercept
VEGF Trap, VEGF Trap-Eye
+1 more
|
EGFR Inhibitor | 3 | — | View → |
|
Aldesleukin
125-L-serine-2-133-interleukin 2 (human reduced), Interleukin-2 aldesleukin
+2 more
|
Tyrosine Kinase Inhibitor | 3 | — | View → |
|
Alemtuzumab
|
— | 11 | — | View → |
|
Alitretinoin
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, (7E,9Z,11E,13E)-retinoic acid
+7 more
|
Retinoid | 9 | — | View → |
|
Altretamine
2,4,6-Tris(dimethylamino)-1,3,5-triazine, 2,4,6-Tris(dimethylamino)-S-triazine
+7 more
|
Alkylating Agent | 0 | — | View → |
|
Aminoglutethimide
2-(p-Aminophenyl)-2-ethylglutarimide, 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine
+9 more
|
Hormone Therapy | 2 | — | View → |
|
Amrubicin
|
Topoisomerase Inhibitor | 1 | — | View → |
|
Amsacrine
4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide, 4'-(9-Acridinylamino)methanesulfon-m-anisidide
+6 more
|
Topoisomerase Inhibitor | 4 | — | View → |
|
Anastrozole
alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile, Anastrozol
|
Hormone Therapy | 1 | — | View → |
|
Arsenic trioxide
Acide Arsenieux, Anhydride Arsenieux
+10 more
|
— | 10 | — | View → |
|
Asparaginase
Asparaginase (E. coli), Escherichia coli L-asparaginase
+2 more
|
— | 0 | — | View → |
|
Axitinib
axitinib, axitinibum
|
EGFR Inhibitor | 3 | — | View → |
|
Azacitidine
4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one, 5 AZC
+5 more
|
— | 1 | — | View → |
|
Belinostat
|
HDAC Inhibitor | 1 | — | View → |
|
Bendamustine
Ribomustine
|
Alkylating Agent | 0 | — | View → |
|
Bevacizumab
antiVEGF, bevacizumab-awwb
|
VEGFR Inhibitor | 11 | — | View → |
|
Bexarotene
4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid, 4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid
+9 more
|
Retinoid | 3 | — | View → |
|
Bicalutamide
Bicalutamida, Bicalutamide
+1 more
|
Androgen Receptor Antagonist | 1 | — | View → |
|
Bleomycin
Bleocin, Bleomicin
+5 more
|
— | 2 | — | View → |
|
Blinatumomab
|
Monoclonal Antibody | 2 | — | View → |
|
Bortezomib
[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid, N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
+1 more
|
CDK4/6 Inhibitor | 2 | — | View → |
|
Bosutinib
4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile, Bosulif®
+3 more
|
BCR-ABL Inhibitor | 10 | 5 | View → |
|
Brentuximab vedotin
cAC10-vcMMAE
|
Monoclonal Antibody | 1 | — | View → |
|
Buserelin
(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH, D-Ser(Tbu)6EA10LHRH
+2 more
|
— | 2 | — | View → |
|
Busulfan
1,4-Bis(methanesulfonoxy)butane, 1,4-Butanediol dimethanesulfonate
+13 more
|
Alkylating Agent | 0 | — | View → |
|
Cabazitaxel
Cabazitaxelum, Taxoid XRP6258
+2 more
|
Tubulin Inhibitor | 2 | — | View → |
|
Cabozantinib
|
EGFR Inhibitor | 3 | — | View → |
|
Capecitabine
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester, Capecitabin
+4 more
|
— | 1 | — | View → |
|
Carboplatin
Carboplatin, CBDCA
+3 more
|
Alkylating Agent | 0 | — | View → |
|
Carfilzomib
|
Proteasome Inhibitor | 6 | — | View → |
|
Carmustine
BCNU, Bicnu (tn)
+6 more
|
— | 1 | — | View → |
|
Catumaxomab
|
— | 0 | — | View → |
|
Ceritinib
céritinib, N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide
|
ALK Inhibitor | 1 | 12 | View → |
|
Cetuximab
Cetuximab, Cétuximab
+2 more
|
EGFR Inhibitor | 12 | 24 | View → |
|
Chlorambucil
4-(P-Bis(beta-chloroethyl)aminophenyl)butyric acid, 4-(p-bis(β-chloroethyl)aminophenyl)butyric acid
+9 more
|
Alkylating Agent | 0 | — | View → |
|
Cisplatin
CDDP, Cis-DDP
+1 more
|
Alkylating Agent | 4 | — | View → |
|
Cladribine
(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol, 2-CdA
+10 more
|
Antimetabolite | 9 | — | View → |
|
Clofarabine
(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol, 2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
+8 more
|
— | 2 | — | View → |
|
Crizotinib
(R)-crizotinib, Crizotinib
+1 more
|
ALK Inhibitor | 2 | 50 | View → |
|
Cyclophosphamide
(+-)-Cyclophosphamide, (RS)-Cyclophosphamide
+12 more
|
Alkylating Agent | 1 | — | View → |
|
Cytarabine
1-beta-D-Arabinofuranosylcytosine, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
+5 more
|
— | 1 | — | View → |
|
Dabrafenib
Dabrafenib
|
BRAF Inhibitor | 5 | 18 | View → |
|
Dacarbazine
4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide, 4-(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide
+12 more
|
Alkylating Agent | 2 | — | View → |
|
Dactinomycin
2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, ActD
+8 more
|
— | 0 | — | View → |
|
Dasatinib
anh. dasatinib, Anhydrous dasatinib
+6 more
|
BCR-ABL Inhibitor | 23 | — | View → |
|
Daunorubicin
(+)-Daunomycin, (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione
+8 more
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Decitabine
4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one, 5-aza-2'-deoxycytidine
+4 more
|
— | 1 | — | View → |
|
Degarelix
|
— | 1 | — | View → |
|
Denileukin diftitox
Diphtheria toxin precursor, DT
+1 more
|
— | 3 | — | View → |
|
Diethylstilbestrol
(E)-3,4-bis(4-hydroxyphenyl)-3-hexene, (e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol
+14 more
|
Hormone Therapy | 9 | — | View → |
|
Dinutuximab
Dinutuximab beta, Monoclonal antibody ch14.18
|
Monoclonal Antibody | 0 | — | View → |
|
Docetaxel
Docetaxel anhydrous, N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
+2 more
|
BCL-2 Inhibitor | 6 | — | View → |
|
Doxorubicin
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
+6 more
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Enzalutamide
|
Androgen Receptor Antagonist | 1 | 8 | View → |
|
Epirubicin
4'-Epiadriamycin, Epiadriamycin
+7 more
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Eribulin
|
Tubulin Inhibitor | 2 | — | View → |
|
Erlotinib
[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine, Erlotinib
+1 more
|
EGFR Inhibitor | 2 | 6 | View → |
|
Estramustine
17beta-Estradiol 3-(bis(2-chloroethyl)carbamate), 17β-Estradiol 3-(bis(2-chloroethyl)carbamate)
+4 more
|
Hormone Therapy | 4 | — | View → |
|
Ethinyl Estradiol
17-ethinyl-3,17-estradiol, 17-ethinyl-3,17-oestradiol
+8 more
|
Hormone Therapy | 3 | — | View → |
|
Etoposide
(−)-etoposide, 4-demethylepipodophyllotoxin β-D-ethylideneglucoside
+5 more
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Everolimus
40-O-(2-hydroxyethyl)-rapamycin
|
mTOR Inhibitor | 1 | 2 | View → |
|
Exemestane
6-Methyleneandrosta-1,4-diene-3,17-dione, Exemestane
+2 more
|
Hormone Therapy | 1 | — | View → |
|
Filgrastim
Filgrastim-sndz, G-CSF
+2 more
|
— | 2 | — | View → |
|
Fludarabine
2-F-ARAA, 2-fluoro ARA-A
|
Antimetabolite | 3 | — | View → |
|
Fluorouracil
5-Fluoracil, 5-Fluoropyrimidine-2,4-dione
+10 more
|
— | 1 | — | View → |
|
Flutamide
4'-Nitro-3'-trifluoromethylisobutyranilide, alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide
+8 more
|
Androgen Receptor Antagonist | 3 | 14 | View → |
|
Formestane
4-hydroxy-4-androstene-3,17-dione, 4-Hydroxy-delta(4)-androstenedione
+6 more
|
Hormone Therapy | 0 | — | View → |
|
Fulvestrant
ICI 182,780
|
Hormone Therapy | 1 | — | View → |
|
Gefitinib
4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline, Gefitinib
+2 more
|
EGFR Inhibitor | 1 | 7 | View → |
|
Gemcitabine
2'-Deoxy-2',2'-difluorocytidine, 2',2'-Difluorodeoxycytidine
+5 more
|
— | 3 | — | View → |
|
Gemtuzumab ozogamicin
|
— | 12 | — | View → |
|
Goserelin
|
— | 2 | — | View → |
|
Histrelin
[(im-Bzl)-D-His6,Pro9-NEt]-gonadotropin releasing hormone, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
+5 more
|
— | 1 | — | View → |
|
Hydroxyurea
Carbamohydroxamic Acid, Carbamohydroximic Acid
+11 more
|
Alkylating Agent | 1 | — | View → |
|
Ibrutinib
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
|
BTK Inhibitor | 1 | 11 | View → |
|
Idarubicin
(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, 4-Demethoxydaunomycin
+5 more
|
Topoisomerase Inhibitor | 1 | — | View → |
|
Idelalisib
5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one, 5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one
|
PI3K Inhibitor | 0 | — | View → |
|
Ifosfamide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, Ifosfamida
+5 more
|
Alkylating Agent | 1 | — | View → |
|
Imatinib
4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide, alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide
+4 more
|
BCR-ABL Inhibitor | 9 | 91 | View → |
|
Interferon Alfa-2a, Recombinant
Interferon alfa-2a, Interferon alfa-2a (recombinant)
+8 more
|
Tyrosine Kinase Inhibitor | 2 | — | View → |
|
Interferon Alfa-2b, Recombinant
Interferon alfa-2b, Interferon α-2b
+3 more
|
Tyrosine Kinase Inhibitor | 2 | — | View → |
|
Interferon alfacon-1
CIFN, consensus interferon
+7 more
|
Tyrosine Kinase Inhibitor | 2 | — | View → |
|
Ipilimumab
MDX-010, MDX-101
+2 more
|
Monoclonal Antibody | 1 | — | View → |
|
Irinotecan
Biotecan, Camptothecin-11
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Ixabepilone
Aza-epothilone B, Azaepothilone B
|
Tubulin Inhibitor | 1 | — | View → |
|
Ixazomib
|
Proteasome Inhibitor | 0 | — | View → |
|
Lapatinib
FMM, GW 572016
+3 more
|
EGFR Inhibitor | 2 | — | View → |
|
Lenalidomide
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline, 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
+4 more
|
— | 4 | — | View → |
|
Lenograstim
G-CSF (CHO cell derived), Glycosylated recombinant G-CSF
+5 more
|
— | 1 | — | View → |
|
Lenvatinib
4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide, Lenvatinib Mesylate
|
EGFR Inhibitor | 8 | — | View → |
|
Letrozole
Letrozol
|
Hormone Therapy | 1 | — | View → |
|
Leuprolide
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone, L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
+6 more
|
— | 1 | — | View → |
|
Lomustine
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-(2-Chloroethyl)-3-cyclohexylnitrosourea
+8 more
|
Alkylating Agent | 1 | — | View → |
|
Masoprocol
erythro-nordihydroguaiaretic acid, Masoprocolum
+9 more
|
— | 2 | — | View → |
|
Mechlorethamine
2,2'-dichloro-N-methyldiethylamine, beta,Beta'-dichlorodiethyl-N-methylamine
+11 more
|
Alkylating Agent | 0 | — | View → |
|
Medroxyprogesterone acetate
(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione, 17-Acetoxy-6alpha-methylprogesterone
+16 more
|
— | 2 | — | View → |
|
Megestrol acetate
17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
+17 more
|
— | 2 | — | View → |
|
Melphalan
3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine, 3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine
+14 more
|
Alkylating Agent | 0 | — | View → |
|
Mercaptopurine
6 MP, 6-Mercaptopurine
+7 more
|
— | 3 | — | View → |
|
Methotrexate
4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid
+7 more
|
— | 1 | — | View → |
|
Mitomycin
7-Amino-9alpha-methoxymitosane, Ametycine
+5 more
|
Alkylating Agent | 0 | — | View → |
|
Mitotane
Mitotan, Mitotane
+3 more
|
— | 5 | — | View → |
|
Necitumumab
|
EGFR Inhibitor | 1 | — | View → |
|
Nelarabine
2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine, Nelzarabine
|
— | 1 | — | View → |
|
Nilotinib
Nilotinibum
|
BCR-ABL Inhibitor | 2 | 3 | View → |
|
Nilutamide
5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin, Nilutamida
+2 more
|
Androgen Receptor Antagonist | 1 | — | View → |
|
Nivolumab
|
Checkpoint Inhibitor | 1 | — | View → |
|
Obinutuzumab
Afutuzumab
|
Monoclonal Antibody | 1 | — | View → |
|
Ofatumumab
HuMax-CD20, Ofatumumab
+1 more
|
Monoclonal Antibody | 1 | — | View → |
|
Olaparib
4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one
|
PARP Inhibitor | 3 | — | View → |
|
Oxaliplatin
Diaminocyclohexane Oxalatoplatinum, L-OHP
+5 more
|
— | 0 | — | View → |
|
Paclitaxel
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
+2 more
|
BCL-2 Inhibitor | 6 | — | View → |
|
Palbociclib
6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
|
CDK4/6 Inhibitor | 2 | 27 | View → |
|
Panitumumab
ABX-EGF
|
EGFR Inhibitor | 1 | 14 | View → |
|
Panobinostat
(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide, panobinostat
|
Proteasome Inhibitor | 1 | — | View → |
|
Pazopanib
GW 78603, Pazopanibum
|
VEGFR Inhibitor | 10 | — | View → |
|
Pegaspargase
Peg-asparaginase, Peg/L-asparaginase
|
— | 0 | — | View → |
|
Pegfilgrastim
Granulocyte colony-stimulating factor pegfilgrastim, Peg-filgrastim
|
— | 2 | — | View → |
|
Pembrolizumab
Lambrolizumab
|
Checkpoint Inhibitor | 1 | 2 | View → |
|
Pemetrexed
|
— | 4 | — | View → |
|
Pentostatin
Co-vidarabine, Pentostatin
+3 more
|
— | 1 | — | View → |
|
Pertuzumab
2C4 Antibody, MOAB 2C4
+3 more
|
HER2 Inhibitor | 1 | — | View → |
|
Pipobroman
Vercyte
|
Alkylating Agent | 0 | — | View → |
|
Pixantrone
6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione, PIX
|
Alkylating Agent | 0 | — | View → |
|
Plerixafor
|
— | 1 | — | View → |
|
Plicamycin
Aureolic acid, Mithramycin
+5 more
|
— | 0 | — | View → |
|
Pomalidomide
|
— | 3 | — | View → |
|
Ponatinib
AP 24534, Ponatinibum
|
BCR-ABL Inhibitor | 15 | — | View → |
|
Porfimer sodium
Porfimer natrium, Porfimer sodico
+2 more
|
— | 2 | — | View → |
|
Pralatrexate
(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid, (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid
+5 more
|
— | 2 | — | View → |
|
Procarbazine
1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine, 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine
+10 more
|
— | 1 | — | View → |
|
Raltitrexed
Raltitrexed
|
— | 2 | — | View → |
|
Ramucirumab
|
EGFR Inhibitor | 1 | — | View → |
|
Regorafenib
Regorafenib, Régorafénib
+1 more
|
EGFR Inhibitor | 18 | — | View → |
|
Rituximab
AntiCD20
|
Monoclonal Antibody | 12 | — | View → |
|
Romidepsin
chromodax
|
HDAC Inhibitor | 5 | — | View → |
|
Sargramostim
GM-CSF
|
— | 5 | — | View → |
|
Sipuleucel-T
Sipuleucel-T
|
— | 1 | — | View → |
|
Sonidegib
Erismodegib, N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
|
Hedgehog Inhibitor | 1 | — | View → |
|
Sorafenib
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide, N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
+1 more
|
EGFR Inhibitor | 10 | 4 | View → |
|
Streptozocin
2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose, 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose
+8 more
|
Alkylating Agent | 2 | — | View → |
|
Sunitinib
Sunitinibum
|
EGFR Inhibitor | 8 | 6 | View → |
|
Tamoxifen
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine, (Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
+18 more
|
Hormone Therapy | 9 | — | View → |
|
Tegafur
1-(2-Tetrahydrofuryl)-5-fluorouracil
|
— | 0 | — | View → |
|
Temozolomide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-D)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-Methyl-4-oxoimidazo(5,1-D)-1,2,3,5-tetrazine-8-carboxamide
+16 more
|
Alkylating Agent | 0 | — | View → |
|
Temsirolimus
42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin
|
mTOR Inhibitor | 1 | — | View → |
|
Teniposide
4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside), Epidophyllotoxin
+4 more
|
Topoisomerase Inhibitor | 1 | — | View → |
|
Thiotepa
|
— | 0 | — | View → |
|
Tioguanine
2-Amino 6mp, 2-Amino-1,7-dihydro-6H-purine-6-thione
+19 more
|
— | 0 | — | View → |
|
Topotecan
9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin, Topotecane
+1 more
|
Topoisomerase Inhibitor | 2 | — | View → |
|
Toremifene
Toremifeno, Toremifenum
|
Hormone Therapy | 2 | — | View → |
|
Trabectedin
Ecteinascidin 743
|
Alkylating Agent | 0 | — | View → |
|
Trametinib
GSK 1120212, Trametinib Dimethyl Sulfoxide
+1 more
|
BRAF Inhibitor | 2 | — | View → |
|
Trastuzumab
RHUMAB HER2, trastuzumab-dkst
|
HER2 Inhibitor | 13 | 4 | View → |
|
Trastuzumab emtansine
Ado-trastuzumab, Ado-trastuzumab emtansine
+4 more
|
HER2 Inhibitor | 1 | — | View → |
|
Tretinoin
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
+25 more
|
Retinoid | 19 | — | View → |
|
Triptorelin
(6-D-Tryptophan)luteinizing hormone-releasing hormone, (D-Trp6)-GnRH
+5 more
|
— | 1 | — | View → |
|
Valrubicin
(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate, 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
+4 more
|
Topoisomerase Inhibitor | 1 | — | View → |
|
Vedolizumab
|
Monoclonal Antibody | 2 | — | View → |
|
Vemurafenib
BRAF(V600E) Kinase Inhibitor RO5185426
|
BRAF Inhibitor | 1 | 31 | View → |
|
Vinblastine
Vinblastin, Vinblastina
+3 more
|
Tubulin Inhibitor | 6 | — | View → |
|
Vincristine
22-Oxovincaleukoblastin, 22-Oxovincaleukoblastine
+4 more
|
Tubulin Inhibitor | 2 | — | View → |
|
Vindesine
3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine, 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine
+1 more
|
Tubulin Inhibitor | 1 | — | View → |
|
Vinorelbine
5'-Noranhydrovinblastine, Nor-5'-anhydrovinblastine
+4 more
|
Tubulin Inhibitor | 1 | — | View → |
|
Vismodegib
Hedgehog Antagonist GDC-0449, Vismodegibum
|
Hedgehog Inhibitor | 1 | 10 | View → |
|
Vorinostat
Octanedioic acid hydroxyamide phenylamide, SAHA
+4 more
|
HDAC Inhibitor | 5 | — | View → |